Stay updated with breaking news from 0fgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stifel Nicolaus upgraded shares of FibroGen (NASDAQ:FGEN – Get Rating) from a hold rating to a buy rating in a research note released on Thursday, The Fly reports. They currently have $32.00 target price on the biopharmaceutical company’s stock, up from their prior target price of $23.00. FGEN has been the topic of several other […]
FibroGen, Inc. (NASDAQ:FGEN – Get Rating) EVP Mark Eisner sold 1,090 shares of the company’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $18.83, for a total transaction of $20,524.70. Following the completion of the transaction, the executive vice president now owns 164,904 shares of the […]
Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Rating) have earned an average rating of “Hold” from the seven analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have issued a buy recommendation on the company. The average […]
M-Kopa said on Monday that the capital injection includes Sh7.5 billion ($55 million) and Sh27.4 billion ($200 million) in debt.
FibroGen (NASDAQ:FGEN – Get Rating) posted its earnings results on Monday. The biopharmaceutical company reported ($0.81) EPS for the quarter, missing the consensus estimate of ($0.76) by ($0.05), Briefing.com reports. The company had revenue of $36.16 million for the quarter, compared to the consensus estimate of $31.52 million. FibroGen had a negative net margin of […]